Sandoz lays foundation stone for new biosimilars centre
Ljubljana, 19 April - The Swiss pharma giant Sandoz lay the foundation stone for a new biosimilars development centre in Ljubljana on Friday. The EUR 90 million investment will create around 200 jobs and is expected to be completed in 2026.
Ljubljana
Swiss generics maker Sandoz holds the foundation-stone laying ceremony for a Biosimilars Development Centre in Ljubljana.
Photo: Nebojša Tejić/STA
Ljubljana
Prime Minister Robert Golob addresses the foundation-stone laying ceremony for a Sandoz Biosimilars Development Centre in Ljubljana.
Photo: Nebojša Tejić/STA
Ljubljana
Swiss generics maker Sandoz holds the foundation-stone laying ceremony for a Biosimilars Development Centre in Ljubljana.
Photo: Nebojša Tejić/STA
Ljubljana
Sandoz CEO Richard Saynor addresses the foundation-stone laying ceremony for a Biosimilars Development Centre in Ljubljana.
Photo: Nebojša Tejić/STA
Ljubljana
Swiss generics maker Sandoz holds the foundation-stone laying ceremony for a Biosimilars Development Centre in Ljubljana.
Photo: Nebojša Tejić/STA
The rest of this news item is available to subscribers.
The news item consists of 1.336 characters (without spaces) or 243 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.